Literature DB >> 8847506

Recombinant baculovirus-expressed NS3 proteinase of hepatitis C virus shows activity in cell-based and in vitro assays.

H Overton1, D McMillan, F Gillespie, J Mills.   

Abstract

Recombinant baculoviruses have been constructed which express the hepatitis C virus (HCV) NS3 proteinase and its substrates in insect cells. The expressed proteinase has been shown to carry out trans-cleavage at the NS3/4A, NS4A/4B, NS4B/5A and NS5A/5B junctions in a cell-based assay. When assayed in a cell-free system using in vitro translated substrates, the proteinase could perform trans-processing of the NS4A/4B and NS5A/5B junctions, but only when coexpressed with NS4A, either as an NS3-4A precursor or by co-infection of cells with NS3- and NS4A-expressing recombinant baculoviruses. Possible reasons for the absolute requirement of the NS3 proteinase for NS4A in vitro are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847506     DOI: 10.1099/0022-1317-76-12-3009

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  In vitro assay for HCV serine proteinase expressed in insect cells.

Authors:  Li-Hua Hou; Gui-Xin Du; Rong-Bin Guan; Yi-Gang Tong; Hai-Tao Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease.

Authors:  S S Taremi; B Beyer; M Maher; N Yao; W Prosise; P C Weber; B A Malcolm
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

3.  Activity of purified hepatitis C virus protease NS3 on peptide substrates.

Authors:  C Steinkühler; A Urbani; L Tomei; G Biasiol; M Sardana; E Bianchi; A Pessi; R De Francesco
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

4.  Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.

Authors:  J M Pawlotsky; G Germanidis; A U Neumann; M Pellerin; P O Frainais; D Dhumeaux
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.